Virtual Medicinal Product (VMP) - Co-amoxiclav 400mg/57mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-amoxiclav 400mg/57mg/5ml oral suspension | Start Date 01-10-2024 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- BAN - British Approved Name
Codes
- BNF Codes
-
- BNF code 05010103
| Code | Start Date | End Date |
|---|---|---|
| 43801211000001105 | 01-10-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Amoxicillin trihydrate | Based on Base Substance | Amoxicillin | 80 mg | 1 ml |
| Potassium clavulanate | Based on Base Substance | Clavulanic acid | 11.4 mg | 1 ml |
Name
Amoxicillin trihydrate
Basis of strength description
Based on Base Substance
BOSS
Amoxicillin
Strength and UOM (Nmr)
80
Strength and UOM (Dmr)
1
Name
Potassium clavulanate
Basis of strength description
Based on Base Substance
BOSS
Clavulanic acid
Strength and UOM (Nmr)
11.4
Strength and UOM (Dmr)
1
Parent Products
-
VTMCo-amoxiclav
-
VMP(Current) Co-amoxiclav 400mg/57mg/5ml oral sus...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 35 ml | 413 | Part VIIIA Category C |
| 70 ml | 579 | Part VIIIA Category C |